Does TIRBANIBULIN Cause Application site vesicles? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Application site vesicles have been filed in association with TIRBANIBULIN (Klisyri). This represents 7.1% of all adverse event reports for TIRBANIBULIN.
14
Reports of Application site vesicles with TIRBANIBULIN
7.1%
of all TIRBANIBULIN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Application site vesicles From TIRBANIBULIN?
Of the 14 reports.
Is Application site vesicles Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRBANIBULIN. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does TIRBANIBULIN Cause?
Drug ineffective (44)
Application site erythema (31)
Drug intolerance (20)
Erythema (18)
Adverse drug reaction (17)
Application site exfoliation (17)
Application site pain (12)
Off label use (11)
Application site dryness (10)
Application site pruritus (9)
What Other Drugs Cause Application site vesicles?
INGENOL MEBUTATE (843)
BUPRENORPHINE (700)
SUMATRIPTAN (262)
NICOTINE (241)
MINOXIDIL (188)
ESTRADIOL (179)
FENTANYL (170)
PICATO (139)
DICLOFENAC (115)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (80)
Which TIRBANIBULIN Alternatives Have Lower Application site vesicles Risk?
TIRBANIBULIN vs TIROFIBAN
TIRBANIBULIN vs TIRZEPATIDE
TIRBANIBULIN vs TISAGENLECLEUCEL
TIRBANIBULIN vs TISLELIZUMAB
TIRBANIBULIN vs TISOTUMAB VEDOTIN